BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28072499)

  • 21. In silico prediction of deleterious non-synonymous SNPs in
    Ajith A; Subbiah U
    Asian Biomed (Res Rev News); 2023 Aug; 17(4):185-199. PubMed ID: 37860678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extrapolating the effect of deleterious nsSNPs in the binding adaptability of flavopiridol with CDK7 protein: a molecular dynamics approach.
    George Priya Doss C; Nagasundaram N; Chakraborty C; Chen L; Zhu H
    Hum Genomics; 2013 Apr; 7(1):10. PubMed ID: 23561625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional and Structural Consequences of Damaging Single Nucleotide Polymorphisms in Human Prostate Cancer Predisposition Gene RNASEL.
    Datta A; Mazumder MH; Chowdhury AS; Hasan MA
    Biomed Res Int; 2015; 2015():271458. PubMed ID: 26236721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Two Novel HOXB13 Germline Mutations in Portuguese Prostate Cancer Patients.
    Maia S; Cardoso M; Pinto P; Pinheiro M; Santos C; Peixoto A; Bento MJ; Oliveira J; Henrique R; Jerónimo C; Teixeira MR
    PLoS One; 2015; 10(7):e0132728. PubMed ID: 26176944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploration of deleterious single nucleotide polymorphisms in late-onset Alzheimer disease susceptibility genes.
    Masoodi TA; Al Shammari SA; Al-Muammar MN; Alhamdan AA; Talluri VR
    Gene; 2013 Jan; 512(2):429-37. PubMed ID: 22960267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In-Silico Analyses of Nonsynonymous Variants in the BRCA1 Gene.
    Arshad S; Ishaque I; Mumtaz S; Rashid MU; Malkani N
    Biochem Genet; 2021 Dec; 59(6):1506-1526. PubMed ID: 33945048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of deleterious single-nucleotide polymorphisms of human LYZ C gene: an in silico study.
    Venkata Subbiah H; Ramesh Babu P; Subbiah U
    J Genet Eng Biotechnol; 2022 Jul; 20(1):92. PubMed ID: 35776277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In silico screening of non-synonymous SNPs in human TUFT1 gene.
    Ajith A; Subbiah U
    J Genet Eng Biotechnol; 2023 Oct; 21(1):95. PubMed ID: 37801178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A computational in silico approach to predict high-risk coding and non-coding SNPs of human PLCG1 gene.
    Khan SM; Faisal AM; Nila TA; Binti NN; Hosen MI; Shekhar HU
    PLoS One; 2021; 16(11):e0260054. PubMed ID: 34793541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Deleterious SNPs and Their Effects on Structural Level in CHRNA3 Gene.
    Chandramohan V; Nagaraju N; Rathod S; Kaphle A; Muddapur U
    Biochem Genet; 2015 Aug; 53(7-8):159-68. PubMed ID: 26002565
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Kumar P; Mahalingam K
    3 Biotech; 2018 Nov; 8(11):466. PubMed ID: 30402368
    [No Abstract]   [Full Text] [Related]  

  • 32. Identification of the SIRT1 gene's most harmful non-synonymous SNPs and their effects on functional and structural features-an
    Thayyil Menambath D; Adiga U; Rai T; Adiga S; Shetty V
    F1000Res; 2023; 12():66. PubMed ID: 38283900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In silico Evaluation of Nonsynonymous Single Nucleotide Polymorphisms in the ADIPOQ Gene Associated with Diabetes, Obesity, and Inflammation.
    Narayana Swamy A; Valasala H; Kamma S
    Avicenna J Med Biotechnol; 2015; 7(3):121-7. PubMed ID: 26306152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In silico analysis of non-synonymous missense SNPs (nsSNPs) in CPE, GNAS genes and experimental validation in type II diabetes mellitus through Next Generation Sequencing.
    Sabiha B; Bhatti A; Roomi S; John P; Ali J
    Genomics; 2021 Jul; 113(4):2426-2440. PubMed ID: 34029697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimation of varicocele associated human ARG2 and NOS1 proteins and computational analysis on the effect of its nsSNPs.
    Karthikeyan V; Vickram AS; Manian R
    Int J Biol Macromol; 2020 Dec; 164():735-747. PubMed ID: 32693129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for familial and hereditary prostate cancer.
    Lynch HT; Kosoko-Lasaki O; Leslie SW; Rendell M; Shaw T; Snyder C; D'Amico AV; Buxbaum S; Isaacs WB; Loeb S; Moul JW; Powell I
    Int J Cancer; 2016 Jun; 138(11):2579-91. PubMed ID: 26638190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In silico analysis of structural and functional consequences in p16INK4A by deleterious nsSNPs associated CDKN2A gene in malignant melanoma.
    Rajasekaran R; Priya Doss CG; Sudandiradoss C; Ramanathan K; Sethumadhavan R
    Biochimie; 2008 Oct; 90(10):1523-9. PubMed ID: 18573309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HOXB13 contributes to G1/S and G2/M checkpoint controls in prostate.
    Hamid SM; Cicek S; Karamil S; Ozturk MB; Debelec-Butuner B; Erbaykent-Tepedelen B; Varisli L; Gonen-Korkmaz C; Yorukoglu K; Korkmaz KS
    Mol Cell Endocrinol; 2014 Mar; 383(1-2):38-47. PubMed ID: 24325868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and structural characterization of deleterious non-synonymous single nucleotide polymorphisms in the human SKP2 gene.
    Hosen SMZ; Dash R; Junaid M; Mitra S; Absar N
    Comput Biol Chem; 2019 Apr; 79():127-136. PubMed ID: 30802828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A bioinformatics approach for the phenotype prediction of nonsynonymous single nucleotide polymorphisms in human cytochromes P450.
    Wang LL; Li Y; Zhou SF
    Drug Metab Dispos; 2009 May; 37(5):977-91. PubMed ID: 19204079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.